Bayer says drug shows promise vs. gastrointestinal cancer

FDA expands approval of Bayer cancer drug

WASHINGTON — The Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that don't respond to other treatments.The drug is called Stivarga and regulators approved it to treat gastrointestinal stromal tumors that cannot be surgically removed and no longer respond to other FDA-approved drugs.The FDA previously...

bostonherald.com (2 months and 22 days ago)

India rejects Bayer plea against cheap cancer drug

NEW DELHI (AP) -- India's patent appeals office has rejected international drug maker Bayer AG's plea to stop an Indian company from manufacturing a cheaper generic version of a patented cancer drug....

ap.org (2 months and 15 days ago)

FDA expands approval of Bayer cancer drug

The Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that don't respond to other treatments

northjersey.com (2 months and 22 days ago)

India rejects Bayer plea against cheap cancer drug

India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important prec…

azstarnet.com (2 months and 15 days ago)

Bayer Gets FDA Approval for Advanced Prostate Cancer Drug

Federal regulators approved a new drug Wednesday from Bayer to treat certain types of advanced prostate cancer.

wsj.com (2 days ago)

India rules against Bayer in cancer drug patent case

An Indian patent appeals board dismissed on Monday Bayer AG's petition against a government decision to allow a domestic company to sell cheap copycat versions of cancer drug Nexavar, delivering a blow to global drugmakers' monopolies on high-priced medicines.

moneycontrol.com (2 months and 15 days ago)

India rejects Bayer plea against cheap cancer drug

India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive lifesaving medicines to the poor.

philly.com (2 months and 14 days ago)

India rejects Bayer plea against cheap cancer drug

India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive lifesaving medicines to the poor.

cbc.ca (2 months and 15 days ago)

India rejects Bayer plea against cheap cancer drug

NEW DELHI (AP) — India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive lifesaving medicines to the poor.

boston.com (2 months and 15 days ago)

FDA Approves Bayer Drug Stivarga for Rare Gastrointestinal Tumor

foxbusiness.com (2 months and 22 days ago)